Rodríguez-Labrada Roberto, Velázquez-Pérez Luis, Ortega-Sánchez Ricardo, Peña-Acosta Arnoy, Vázquez-Mojena Yaimeé, Canales-Ochoa Nalia, Medrano-Montero Jacqueline, Torres-Vega Reidenis, González-Zaldivar Yanetza
Centre for the Research and Rehabilitation of Hereditary Ataxias, Libertad Street # 26, 80100 Holguín, Cuba.
2Faculty of Sport and Physical Culture, University of Holguín, Holguín, Cuba.
Cerebellum Ataxias. 2019 Mar 4;6:3. doi: 10.1186/s40673-019-0097-2. eCollection 2019.
Cognitive decline is a common non-motor feature characterizing Spinocerebellar Ataxia type 2 (SCA2) during the prodromal stage, nevertheless a reduced number of surrogate biomarkers of these alterations have been described.
To provide insights into cognitive dysfunction in SCA2 patients using P300 event-related potentials (ERP) and to evaluate these measures as biomarkers of the disease.
A cross-sectional study was performed with 30 SCA2 patients, 20 preclinical carriers and 33 healthy controls, who underwent visual, auditory P300 ERPs, and neurological examinations and ataxia scoring.
SCA2 patients showed significant increase in P300 latencies and decrease of P300 amplitudes for visual and auditory stimuli, whereas preclinical carriers exhibit a less severe, but significant prolongation of P300 latencies. Multiple regression analyses disclosed a significant effect of SARA score on visual P300 abnormalities in patients as well as of the time to ataxia onset on visual P300 latencies in preclinical carriers.
This paper demonstrated the role of P300 ERP for the study of attentional, discriminative and working memory abnormalities in SCA2 patients and for the search of surrogate biomarkers from prodromal to the symptomatic stages. Moreover, our findings provide psychophysiological evidences supporting the cerebellar involvement in cognitive processes and allows us to identify promising outcome measures for future trials focusing on cognitive dysfunction.
认知衰退是2型脊髓小脑共济失调(SCA2)前驱期常见的非运动特征,然而关于这些改变的替代生物标志物数量却很少被描述。
利用P300事件相关电位(ERP)深入了解SCA2患者的认知功能障碍,并评估这些指标作为该疾病生物标志物的情况。
对30例SCA2患者、20例临床前携带者和33名健康对照进行了横断面研究,这些受试者接受了视觉、听觉P300 ERP检查、神经学检查和共济失调评分。
SCA2患者在视觉和听觉刺激下P300潜伏期显著延长,P300波幅降低,而临床前携带者P300潜伏期虽延长程度较轻但也有显著延长。多元回归分析显示,SARA评分对患者视觉P300异常有显著影响,临床前携带者共济失调发病时间对视觉P300潜伏期有显著影响。
本文证明了P300 ERP在研究SCA2患者注意力、辨别力和工作记忆异常以及从前驱期到症状期寻找替代生物标志物方面的作用。此外,我们的研究结果提供了心理生理学证据,支持小脑参与认知过程,并使我们能够确定针对认知功能障碍的未来试验有前景的结局指标。